Frozen Shoulder Syndrome Market Grows Amid Advances in Arthroscopic and Robotic Treatments | GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc.

The Frozen Shoulder Syndrome Market is estimated to reach at a Significant CAGR during the forecast period (2024-2031).

Frozen Shoulder Syndrome, or adhesive capsulitis, is a condition marked by stiffness and pain in the shoulder joint. It occurs when the capsule surrounding the joint thickens and tightens, restricting movement. The condition often develops gradually and can last months to years. Common causes include injury, diabetes, or prolonged immobilization. Treatment includes physical therapy, corticosteroid injections, and, in severe cases, surgical release. Early intervention helps restore mobility and prevent long-term disability.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Frozen Shoulder Syndrome Market Landscape:- https://datamintelligence.com/download-sample/frozen-shoulder-syndrome-market?Ranjith

☛ Frozen Shoulder Syndrome Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In July 2025, Boston Scientific launched an advanced minimally invasive arthroscopic system for adhesive capsulitis treatment, improving patient recovery time and reducing post-operative stiffness.

✅ In June 2025, Zimmer Biomet introduced injectable hyaluronic acid-based therapies for frozen shoulder, aimed at pain relief and improving joint mobility without surgery.

✅ In May 2025, Medi-Tec Inc. expanded clinical trials for a robot-assisted shoulder mobilization device, enabling precise physiotherapy interventions for frozen shoulder patients.

Japan: Recent Industry Developments

✅ In July 2025, Olympus Corporation developed high-definition arthroscopic tools for shoulder capsule release procedures, improving surgical accuracy and patient outcomes.

✅ In June 2025, Terumo Corporation initiated research into bioengineered growth factor injections to accelerate tissue healing and restore shoulder mobility.

✅ In May 2025, Kobe University Hospital partnered with medical device companies to pilot smart physiotherapy devices that guide patients through optimized exercises to reduce frozen shoulder symptoms.

☛ Frozen Shoulder Syndrome Market Competitive Landscape:

GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc., Vintage Pharma, Dr. Reddy's Laboratories Ltd, Marksans Pharma, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Perrigo Company plc, Johnson & Johnson Services, Inc, .), Shanghai Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical GroupCo., Ltd. and Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/frozen-shoulder-syndrome-market?Ranjith

☛ Segments Covered in the Frozen Shoulder Syndrome Market:

By Treatment: Physical therapy, Medication, Joint distension, Surgery, Others.

By End-user: Hospitals, Homecare, Other.

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Frozen Shoulder Syndrome Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=frozen-shoulder-syndrome-market?Ranjith

☛ Regional Analysis for Frozen Shoulder Syndrome Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.